---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-080896"
form_type: "8-K"
ticker: "KYTX"
cik: "0001994702"
company_name: "Kyverna Therapeutics, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T02:01:44.089703+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Kyverna Therapeutics shareholders elect two Class I directors and ratify BDO as auditor at 2025 Annual Meeting

## Summary
- 30,546,469 shares (70.67% of outstanding) represented at May 29, 2025 Annual Meeting.
- Beth Seidenberg, M.D. elected with 18,161,970 votes for, 2,508,848 withheld.
- Fred E. Cohen, M.D., D. Phil. elected with 18,513,181 votes for, 2,157,637 withheld.
- Ratification of BDO USA, P.C. as auditor for 2025 passed with 30,374,716 for, 142,212 against, 29,541 abstain.

## SEC filing metadata
- accession: 0000950170-25-080896
- form_type: 8-K
- ticker: KYTX
- cik: 0001994702
- company_name: Kyverna Therapeutics, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/0000950170-25-080896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/kytx-20250529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-080896
- JSON: https://secwatch.observer/filing/0000950170-25-080896.json
- Plain text: https://secwatch.observer/filing/0000950170-25-080896.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.